中国P站

ISSN: 2476-2024

Diagnostic Pathology: Open Access
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Constructing a Neutrophil Extracellular Trap Model Based on Machine Learning to Predict Clinical Outcomes and Immunotherapy Response in Renal Cell Carcinoma

Yihao Zhu, Xuwen Li, Yajian Li, Yuan Yu, Yabo Zhai, Can Chen, Mingshuai Wang, Dong Chen, Nianzeng Xing, Feiya Yang and Xiongjun Ye
*Corresponding Author:

Received Date: Dec 09, 2024 / Published Date: Sep 17, 2026

Citation: Zhu Y, Li X, Li Y, Yu Y, Zhai Y, et al. (2026) Constructing a Neutrophil Extracellular Trap Model Based on Machine Learning to Predict Clinical Outcomes and Immunotherapy Response in Renal Cell Carcinoma. Diagnos Pathol Open 11: 275.

Copyright: © 2026 Zhu Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Neutrophil Extracellular Traps (NETs) represent a novel form of inflammatory cell death within neutrophils. Emerging research indicates that NETs promote cancer progression and metastasis in various ways. This study aims to provide prognostic NETs characteristics and therapeutic targets for patients with Renal Cell Carcinoma (RCC). NMF analysis was conducted on 89 NET-related genes in the training cohort. Subsequently, WGCNA networks were utilized to study the subtype feature genes. Six machine learning algorithms were assessed for model training and the optimal model was selected based on 1-year, 3-year and 5-year AUC values. A NETs signature was then constructed to predict overall survival in RCC patients. Furthermore, multi-omics validation was performed based on NETs signature. Finally, stable knockout key gene RCC cell lines were established to verify the biological function of KCNN4 both in vitro and in vivo. This study highlights the emerging hot topic of NETs in RCC. We provide a prognostic NETs signature and identify multiple roles of KCNN4 in RCC. This work contributes to risk stratification and the identification of new therapeutic targets for RCC patients.

Keywords

International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top